Literature DB >> 8820115

Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.

E de Faria1, L G Fong, M Komaromy, A D Cooper.   

Abstract

Studies were carried out in mice utilizing inhibitors of several cell surface molecules to evaluate their relative roles in chylomicron remnant removal. Anti-LDL receptor antibody inhibited approximately 45% of rapid remnant removal from plasma, prolonged their half life (63 s to 115 s) and reduced hepatic uptake by 45%. Receptor-associated protein (RAP) (1 mg/mouse), a high affinity inhibitor of the LDL receptor-related protein (LRP) and a low affinity inhibitor of the LDL receptor decreased remnant removal approximately 55%, prolonged the half life from 63 s to 230 s, and reduced hepatic uptake by 70%. RAP, but not anti-LDL receptor antibody, inhibited splenic uptake. With both injected together, an incremental effect was seen; plasma removal decreased 60%, T1/2 increased to 290 s, and hepatic uptake decreased by 80%. Thus, it is likely that virtually all of the very rapid removal of remnants from the plasma by the liver requires the presence of at least one of these members of the LDL receptor family. Anti-hepatic lipase antibody caused a small but significant delay in remnant removal from plasma and a larger decrease in hepatic uptake (22.5%). It doubled adrenal uptake. The anti-hepatic lipase antibody was not additive with either the anti-LDL receptor antibody or RAP. Anti-rat hepatic lipase antibody did not inhibit lipolysis by mouse hepatic lipase, suggesting that lipolysis is not the way hepatic lipase enhances remnant uptake. Hepatic lipase bound to remnants to a greater degree than it bound to other lipoproteins. Together these data suggest that hepatic lipase may serve as a binding site for chylomicron remnants, thereby enhancing their affinity for the liver surface, and thus removal by the proteins of the LDL receptor family. Other molecules may also play a role in removal from the circulation under conditions where the LDL receptor family receptors are absent or occupied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820115

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Maturation and secretion of rat hepatic lipase is inhibited by alpha1B-adrenergic stimulation through changes in Ca2+ homoeostasis: thapsigargin and EGTA both mimic the effect of adrenaline.

Authors:  B P Neve; A J Verhoeven; I Kalkman; H Jansen
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.

Authors:  N Srivastava; P R Chowdhury; M Averna; R A Srivastava
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

4.  LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells.

Authors:  Salman Azhar; Satyanarayana Medicherla; Wen-Jun Shen; Yoshio Fujioka; Loren G Fong; Eve Reaven; Allen D Cooper
Journal:  J Lipid Res       Date:  2006-08-23       Impact factor: 5.922

5.  Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase.

Authors:  Sung-Joon Lee; Sujata Kadambi; Kenneth C-W Yu; Christopher David; Salman Azhar; Allen D Cooper; Sungshin Y Choi
Journal:  J Lipid Res       Date:  2004-11-01       Impact factor: 5.922

6.  Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Authors:  Serena M Pratt; Sally Chiu; Glenda M Espinal; Noreene M Shibata; Howard Wong; Craig H Warden
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

Review 7.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

8.  Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.

Authors:  Erin M Foley; Philip L S M Gordts; Kristin I Stanford; Jon C Gonzales; Roger Lawrence; Nicole Stoddard; Jeffrey D Esko
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

9.  Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects.

Authors:  Carmen G Vinagre; Fatima R Freitas; Carlos H de Mesquita; Juliana C Vinagre; Ana Carolina Mariani; Roberto Kalil-Filho; Raul C Maranhão
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

10.  Inhibitory action of benzo[α]pyrene on hepatic lipoprotein receptors in vitro and on liver lipid homeostasis in mice.

Authors:  Hamed Layeghkhavidaki; Marie-Claire Lanhers; Samina Akbar; Lynn Gregory-Pauron; Thierry Oster; Nathalie Grova; Brice Appenzeller; Jordane Jasniewski; Cyril Feidt; Catherine Corbier; Frances T Yen
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.